A new survey published by a precision medicine stakeholder group shows that, while most Americans have never heard of personalized or precision medicine, most had positive reactions when they were told what it was. Still, the survey found that many respondents were concerned about related topics such as privacy of personal genetic information and whether personalized testing and treatments would be covered by insurers. At a panel discussion on Wednesday (May 23), government and industry representatives empathized with those concerns,...